Pharmaceutical group ยท Spain
Esteve
A group of 9 companies with 118 medicines in 7 countries.
Group structure
9 companies in 6 countries
Loading your pageโฆ
Loading your pageโฆ
Pharmaceutical group ยท Spain
A group of 9 companies with 118 medicines in 7 countries.
9 companies in 6 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1โ25 of 118
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Aldactone 100 mg tvrde kapsulekapsula, tvrda | Spironolactone | Croatia | Marketed | 2019 |
| Aldactone 25 mg obloลพene tableteobloลพena tableta | Spironolactone | Croatia | Marketed | 2019 |
| Aldactone 50 mg obloลพene tableteobloลพena tableta | Spironolactone | Croatia | Marketed | 2019 |
| ALZERTA 13,3 MG/24 H PARCHES TRANSDERMICOS EFG19,2 mg ยท Parche transdรฉrmico | Rivastigmine | Spain | Marketed | 2020 |
| ALZERTA 4,6 MG/24 H PARCHES TRANSDERMICOS EFG6,9 mg ยท Parche transdรฉrmico | Rivastigmine | Spain | Marketed | 2020 |
| ALZERTA 9,5 MG/24 H PARCHES TRANSDERMICOS EFG13,8 mg ยท Parche transdรฉrmico | Rivastigmine | Spain | Marketed | 2020 |
| ALZERTA DOS POR SEMANA 4,6 MG/24 H PARCHES TRANSDERMICOS25,92 mg ยท Parche transdรฉrmico | Rivastigmine | Spain | Marketed | 2021 |
| ALZERTA DOS POR SEMANA 9,5 MG/24 H PARCHES TRANSDERMICOS51,84 mg ยท Parche transdรฉrmico | Rivastigmine | Spain | Marketed | 2021 |
| AREMIS 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA111,9 mg ยท Comprimido recubierto con pelรญcula | Sertraline | Spain | Marketed | 1993 |
| AREMIS 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA55,950 mg ยท Comprimido recubierto con pelรญcula | Sertraline | Spain | Marketed | 1993 |
| BILINA 0,5 mg/ml COLIRIO EN SUSPENSIรN0,54 mg ยท Colirio en suspensiรณn | Levocabastine | Spain | Marketed | 1996 |
| BRENTรN 20 MG/G + 10 MG/G CREMA2,0 g + 1,0 g ยท Crema | Miconazole, Hydrocortisone | Spain | Marketed | 1975 |
| BRIMVERA 2 MG/ML COLIRIO EN SOLUCION EN ENVASE UNIDOSIS2 mg ยท Colirio en soluciรณn en envase unidosis | Brimonidine | Spain | Marketed | 2018 |
| CALMIOX 5 mg/g CREMA0,5 g ยท Crema | Hydrocortisone | Spain | Marketed | 1995 |
| CALMIOX 5 mg/g ESPUMA CUTANEA0,5 g ยท Espuma cutรกnea | Hydrocortisone | Spain | Marketed | 1995 |
| CALODIS 1000 mg/880 UI COMPRIMIDOS EFERVESCENTES2500 mg + 0,0242 mg ยท Comprimido efervescente | Carbonate, Vitamin d | Spain | Marketed | 2006 |
| CANADIOL 100 mg CAPSULAS100 mg ยท Cรกpsula dura | Itraconazole | Spain | Marketed | 1992 |
| Caprelsa | Vandetanib | EU (EMA) | Authorised | 2012 |
| CAPRELSA100 mg ยท Tablet | Vandetanib | Canada | Marketed | 2012 |
| CAPRELSA300 mg ยท Tablet | Vandetanib | Canada | Marketed | 2012 |
| CAPRELSACompressa rivestita con film | Vandetanib | Italy | Authorised | |
| CAPRELSA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA100 mg ยท Comprimido recubierto con pelรญcula | Vandetanib | Spain | Marketed | 2012 |
| Caprelsa, 100 mg filmomhulde tablettenFilmomhulde tablet | Vandetanib | Netherlands | Authorised | 2012 |
| CAPRELSA 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA300 mg ยท Comprimido recubierto con pelรญcula | Vandetanib | Spain | Marketed | 2012 |
| Caprelsa, 300 mg filmomhulde tablettenFilmomhulde tablet | Vandetanib | Netherlands | Authorised | 2012 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 74 | 70 | 4 | CompaniesAll medicines |
| Netherlands | 12 | 12 | 0 | CompaniesAll medicines |
| Italy | 10 | 10 | 0 | CompaniesAll medicines |
| European Union (EMA) | 8 | 7 | 1 | CompaniesAll medicines |
| Croatia | 5 | 5 | 0 | CompaniesAll medicines |
| United States | 5 | 5 | 0 | CompaniesAll medicines |
| Canada | 4 | 4 | 0 | CompaniesAll medicines |
Also in the registers of Brazil, France, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la informaciรณn: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Report an error or request removalCorrections from the company itself are welcome.
Well-known pharmaceutical groups, each with all its companies.
Ranked by their number of medicines.